drugset / Trial / NCT04675944
Effect of BIA 5-1058 on the Steady State Pharmacokinetics of Treprostinil
NaSequentialOpen-labelTreatment
Summary
The purpose of this study is to assess the effect of BIA 5-1058 200 mg on the pharmacokinetic (PK) of treprostinil
Timeline
- Start
- 2018-02-28
- Primary completion
- 2018-05-25
- Completion
- 2018-05-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Treprostinil | Other / unclassified | 1 mg | Oral |
| Subject | zamicastat | Small molecule | 200 mg | Oral |